中投顧問重磅推出產業研究大腦，是"產業研究的數字化高效工具"，歡迎試用體驗！ | ||||
|---|---|---|---|---|
| 產品名稱 | 目標用戶 | 核心功能定位 | 產品介紹 | 試用申請 |
| 產業研究大腦 | 政府、企業內關注產業發展的領導及工作人員 | 產業研究工作的一站式解決方案 | 詳情 > | 申請 > |
聯系電話： 400 008 0586; 0755-82571568
微信掃碼： 
1.MARKETOVERVIEW
·Introduction
DiseaseCharacteristics
Epidemiology
·MarketDefinitionandSegmentation
Definition
Segmentation
2.RESEARCHMETHODOLOGY
·ResearchObjectivesandScope
ResearchMethodology
3.INDUSTRYCHALLENGES
·ChallengesForTheAsthmaTherapeuticsMarket
ChallengesFacedbythePharmaceuticalCompanies
4.EUROPEANASTHMATHERAPEUTICSMARKET
·OverviewandDefinitions
Introduction
MarketEngineeringMeasurementsAnalysis
MarketDrivers
MarketRestraints
CurrentTherapeuticOptions
FutureTherapeuticApproaches
CurrentTreatmentGuidelines
RegulatoryAffairs
·CompetitiveAnalysis
ProfilesofKeyIndustryParticipants
MarketShareAnalysis
5.FORECASTSFORTHEEUROPEANASTHMATHERAPEUTICSMARKET
·Forecasts
PatientForecasts
MarketRevenueForecasts
MarketShareAnalysisByDrugClass
ForecastsofRecentEntrants-Xolair
6.PRICINGANDREIMBURSEMENTINEUROPE
·FactorsAffectingPricingandReimbursementinEurope
PricingandReimbursement
7.STRATEGICRECOMMENDATIONSFORTHEEUROPEANASTHMATHERAPEUTICSMARKET
·MarketEngineeringRecommendations
StrategicRecommendations
8.DATABASEOFKEYINDUSTRYPARTICIPANTS
·KeyIndustryParticipants
KeyParticipantsintheAsthmaTherapeuticsMarket
9.DECISIONSUPPORTDATABASES
·DSDTables
DSD1
DSD2
DSD3
DSD4
This Frost & Sullivan research service titled European Asthma Therapeutics Markets provides key challenges, forecasts and recommendations for the asthma therapeutics market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following markets: short acting beta 2 agonists, inhaled corticosteroids, combination therapies and leukotriene antagonists.
This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Service programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
